M. Mantica

Retrospective study of nivolumab for patients with recurrent high grade gliomas

F. Lieberman, J. Drappatz, M. Mantica, 2018, Journal of Neuro-Oncology.

Immunotherapy associated central nervous system complications in primary brain tumors

J. Drappatz, M. Mantica, 2023, Frontiers in Oncology.

CTIM-13. PHASE 1 CLINICAL TRIAL OF ONCOLYTIC VIRAL IMMUNOTHERAPY WITH CAN-2409 + VALACYCLOVIR IN COMBINATION WITH NIVOLUMAB AND STANDARD OF CARE (SOC) IN NEWLY DIAGNOSED HIGH-GRADE GLIOMA (HGG)

F. Lieberman, P. Wen, R. Strowd, 2021, Neuro-Oncology.

Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.

L. Lunsford, F. Lieberman, A. Niranjan, 2023, Journal of neuro-oncology.

Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme

L. Lunsford, F. Lieberman, A. Niranjan, 2023, Journal of Neuro-Oncology.

Supratentorial lymphocytic inflammation with parenchymal perivascular enhancement responsive to steroids: A case report and literature review

S. Polster, Z. Gersey, M. Mantica, 2021, Surgical neurology international.